Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Voriconazole, a promising treatment for serious fungal infections

Oct. 2, 1998

Review of the preclinical activity of GAR-936, a glycylcycline antibiotic with clinical potential

Oct. 2, 1998

MC-02479/RWJ-54428: in vitro activity and pharmacokinetics in animals

Oct. 1, 1998

Results from human pharmacokinetic studies support once-daily dosing for MK-991

Oct. 1, 1998

MEN-10700 highly active against pneumococci, gonococci and meningococci

Oct. 1, 1998

Promising new rhinovirus 3C protease inhibitor emerges from Agouron R&D

Oct. 1, 1998

Comparative in vitro antipneumococcal activity of CFC-222 presented at ICAAC

Oct. 1, 1998

ICAAC presentation for potent new anti-HCMV agent from RPR with novel mechanism of action

Oct. 1, 1998

Twice-daily Viracept as safe and effective as the approved t.i.d. schedule

Oct. 1, 1998

Major pediatric study supports safety and efficacy of pneumococcal vaccine

Oct. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...